Litigation Details for Novartis Pharmaceuticals Corporation v. Sun Pharmaceutical Industries Ltd. (D. Del. 2021)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Sun Pharmaceutical Industries Ltd. (D. Del. 2021)
Docket | ⤷ Sign Up | Date Filed | 2021-11-23 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Patents | 8,927,574; 9,085,553; 9,353,088; 9,890,141 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Sun Pharmaceutical Industries Ltd.
Details for Novartis Pharmaceuticals Corporation v. Sun Pharmaceutical Industries Ltd. (D. Del. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2022-04-29 | 24 | Notice of Service | Initial Invalidity Contentions Regarding U.S. Patent Nos. 8,927,574; 9,085,553; 9,353,088; 9,890,141 AND 11,…23 November 2021 1:21-cv-01656 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2021-11-22 | 3 | ANDA Form | of Expiration of Patent: December 18, 2033 (11,058,677); November 12, 2030 (8,927,574); October 21, 2030… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …23 November 2021 1:21-cv-01656 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2021-11-22 | 4 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,058,677; 8,927,574; 9,353,088; 9,890,141…23 November 2021 1:21-cv-01656 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |